Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

Continuous glucose monitors (CGMs) are monitoring devices people with diabetes use. They apply them directly to the skin and ...

Abbott’s Freestyle Libre, approved by the FDA in 2017, is one such device. A diabetes diagnosis can come with many difficult lifestyle changes, including frequent blood sugar checks. To check ...

The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above ...

Abbott announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on Amazon.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...

When participants consumed a smoothie, the Abbott Freestyle Libre 2 CGM overestimated the GI by 30%, reporting a GI of 69 (medium) compared to the traditional test result of 53 (low). Whole fruit ...

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma. Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive ...

Abbott had claimed that the shape of Sinocare’s iCan i3 wearable CGM was too similar to its own FreeStyle Libre sensor—in this case, the small, white disc placed on the upper arm. Sinocare ...

For instance, Abbott Laboratories' FreeStyle Libre product line is one of the most lucrative in the continuous glucose monitoring (CGM) market, which is practically a duopoly it shares with DexCom.